Abstract

It is well documented that amyl nitrite can cause methemoglobinemia [1-7]. This condition can be successfully treated with methylene blue therapy [1-8]. Amyl nitrite is used therapeutically as part of the antidote cocktail to treat cyanide poisoning; however, it also carries a high abuse potential

Highlights

  • DiscussionMany drugs are known to cause methemoglobinemia, but few are abused. An exception is amyl nitrite

  • It is well documented that amyl nitrite can cause methemoglobinemia [1,2,3,4,5,6,7]

  • Previous case reports have shown that methemoglobin levels of greater than 70% require multiple doses of methylene blue therapy [4, 7]

Read more

Summary

Discussion

Many drugs are known to cause methemoglobinemia, but few are abused. An exception is amyl nitrite. No laboratory assay is readily available to measure amyl nitrite levels Given this high abuse potential, it is surprising that there were fewer than 60 calls to poison control centers in the US during 2009 related to the use of poppers [2]. In July 2011, the Food and Drug Administration (FDA) issued a safety notice [5] warning practitioners about the risk of serotonin syndrome when methylene blue is utilized concomitantly with medications exhibiting serotonergic effects such as selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, monoamine oxidase inhibitors, and others. No work up was under taken to asses for genetic abnormalities that may have explained why only 2 inhalations may have caused such an abnormally elevated methemoglobin level Another caveat to this case has to due with the use of single dose methylene blue. Clinicians should not expect to see the same results with methylene blue for longer acting agents known to cause methemoglobinemia such as the topical anesthetics or dapsone

Introduction
Findings
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.